Challenges and Expectations for Pfizer

Exploring the hurdles faced by Pfizer such as the patent cliff and disappointing acquisitions, while highlighting the potential for stock growth and attractive dividends.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app